Skip header and navigation
Canadian Medical Association
  • CMA Policybase
  • Home
  • Help
  • Selections 0
  • Ethics and medical professionalism
  • Éthique et professionnalisme médical
  • Pharmaceuticals, prescribing, cannabis, drugs
  • Response to consultation
  • 2018
Print
Sort by Relevance Sort by Newest Sort by Oldest
Gallery View List View
Refine Your Search

Narrow Results By

Topic

  • Ethics and medical professionalism
  • Health care and patient safety 4
  • Pharmaceuticals, prescribing, cannabis, drugs
  • Population health, health equity, public health 3

Policy Type

  • Parliamentary submission 2
  • Policy document 4
  • Policy endorsement 2
  • Response to consultation

Year

  • 2019 2
  • 2018
  • 2017 5
  • 2016 5
  • 2015 1
  • 2014 3
  • Advanced Search
  • Help

8 records – page 1 of 1.

Prev Next
Select Title Policy Type Year
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Federal monitoring of medical assistance in dying regulations Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on Canadian drugs and substances strategy Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on regulatory amendments regarding tramadol Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on restriction of marketing and advertising of opioids Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018
EspAddText
EspRemoveText
Implementation of National Pharmacare Response to consultation 2018
EspAddText
EspRemoveText
Proposed approach to the regulation of cannabis Response to consultation 2018

8 records – page 1 of 1.

Prev Next
  • Privacy
  • Terms & Conditions
  • Accessibility
  • Contact

© 2023 Canadian Medical Association